J Cheng

No ORCID on file · 4 papers in corpus
lab-animal 2022
Peer Review #3 of "BMSC-derived exosomal miR-27a-3p and miR-196b-5p regulate bone remodeling in ovariectomized rats (v0.1)"
·doi:10.7287/peerj.13744v0.1/reviews/3

Background.In the bone marrow microenvironment of postmenopausal osteoporosis (PMOP), bone marrow mesenchymal stem cell (BMSC)-derived exosomal miRNAs play an important role in bone formation and bone resorption, although the pathogenesis h…

nonrandomized-trial 2017
Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.14736

OBJECTIVES: This study was to investigate the clinical efficacy of a gonadotrophin-releasing hormone agonist (GnRH-a) combined with high-intensity focused ultrasound (HIFU) ablation treatment for adenomyosis. DESIGN: A non-randomized prosp…

lab-animal 2011
Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy
British journal of cancer ·doi:10.1038/bjc.2011.88

BACKGROUND: The purpose of this study was to test a novel, dual tumour vascular endothelial cell (VEC)- and tumour cell-targeting factor VII-targeted Sn(IV) chlorin e6 photodynamic therapy (fVII-tPDT) by targeting a receptor tissue factor (…

other 1984
Electron microscopic observations of the effects of gossypol on the human endometrium
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(84)90122-4

Gossypol treatment of endometriosis and uterine myomas in 15 cases was started with a daily dose of 20 mg of gossypol-acetic acid twice a day for 20 days as a loading dose, followed by 40 mg (20 mg twice weekly). A maintenance dose of 20 mg…